Welcome to LookChem.com Sign In|Join Free

CAS

  • or

858197-58-7

Post Buying Request

858197-58-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

858197-58-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 858197-58-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,1,9 and 7 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 858197-58:
(8*8)+(7*5)+(6*8)+(5*1)+(4*9)+(3*7)+(2*5)+(1*8)=227
227 % 10 = 7
So 858197-58-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H17NO2/c1-8(2,7-10)9-3-5-11-6-4-9/h10H,3-7H2,1-2H3

858197-58-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (CBR01801)  2-Methyl-2-(4-morpholinyl)-1-propanol  AldrichCPR

  • 858197-58-7

  • CBR01801-1G

  • 4,512.69CNY

  • Detail

858197-58-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methyl-2-morpholin-4-ylpropan-1-ol

1.2 Other means of identification

Product number -
Other names 2-METHYL-2-(4-MORPHOLINYL)-1-PROPANOL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:858197-58-7 SDS

858197-58-7Downstream Products

858197-58-7Relevant articles and documents

COMPOUNDS

-

Page/Page column 105; 106, (2015/09/23)

The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of or prevention of diseases characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 858197-58-7